Diabetes surveillance aims to provide prompt and periodic reporting on disease dynamics and determinants, quality of care, and secondary diseases.
Diabetes is a chronic disease with huge public health relevance throughout the world. This particularly applies to type 2 diabetes, which is associated with lifestyles and living conditions. The importance of diabetes is due to the prevalence of type 2 diabetes and its potentially avoidable risk factors. It is often associated with comorbidities and complications, a reduction in health-related quality of life and in healthy and general life expectancy. As such, the condition is also costly to the health system.
Against this backdrop, the Robert Koch Institute (RKI) is conducting a research project to develop diabetes surveillance in Germany. The project is funded by the Federal Ministry of Health. In the public health context, surveillance refers to the systematic and continous collection and analysis of health-related data. The aim of diabetes surveillance, therefore, is to establish periodic, indicator-based diabetes reporting to provide prompt and action-oriented information on health policy, health research, health care and public health practices by operationalising the links between data garnered from RKI health monitoring and other relevant sources at the federal and regional levels. The findings should serve as a decision-making aid for planning, implementing and evaluating measures aimed at improving diabetes prevention and care. As a model project, the project is intended to create important requirements for establishing surveillance of other public health-relevant non-communicable diseases (NCD) as part of an intended comprehensive public health surveillance.
The first four-year project phase, ‘Developing National Diabetes Surveillance at the Robert Koch Institute’, the following milestones were to be achieved:
The subsequent two-year project phase, ‘Continuation of ongoing project-related funding for diabetes surveillance’, the following milestones were to be achieved:
The current one-and-a-half-year project phase, ‘Extension of the project Diabetes Surveillance with expansion to an NCD Surveillance’, the following milestones are planned:
The three phases of the project are to be overseen by an interdisciplinary scientific advisory board. In order to ensure that milestones set out above are achieved, the project works with other actors from health policy and public health at the federal and state levels, the Federal Centre for Health Education, professional medical associations and national and international scientific cooperation partners from public health. Furthermore, methodological cooperation projects are also provided with targeted support.